Skip to content

Advertisement

Featured article: Metabolic syndrome is a risk factor for cancer mortality in the general Japanese population: the Jichi Medical School Cohort Study

Metabolic syndrome is a disease characterized by a cluster of high blood glucose, dyslipidemia, obesity, and hypertension. It is an important risk factor for not only cardiovascular diseases but also the development of cancer. Accumulating evidence regarding the clinical value of Metabolic Syndrome in estimating the risk of cancer has led to increased interest in the relationship between Metabolic Syndrome and cancer. 

Articles

  1. Content type: Research

      |  

    Authors: Herlanny Santana Bezerra, Caroline Severo de Assis, Mayara Karla dos Santos Nunes, Isabella Wanderley de Queiroga Evangelista, João Modesto Filho, Cecília Neta Alves Pegado Gomes, Rayner Anderson Ferreira do Nascimento, Rafaella Cristhine Pordeus Luna, Maria José de Carvalho Costa, Naila Francis Paulo de Oliveira and Darlene Camati Persuhn

Most accessed articles RSS

View all articles

Aims and scope

Diabetology & Metabolic Syndrome publishes articles on all aspects of the pathophysiology of diabetes and metabolic syndrome.

By publishing original material exploring any area of laboratory, animal or clinical research into diabetes and metabolic syndrome, the journal offers a high-visibility forum for new insights and discussions into the issues of importance to the relevant community.

The journal aims to help health care providers improve the management of people afflicted by these syndromes by increasing knowledge and stimulating research in the field.

Featured Blog - Listen to Your Gut: A Healthy Biome Holds Clues to Better Health

It’s no secret that our diet affects our health, and now new research suggests that it is actually the bacteria-rich biome in our gut that holds clues to just how harmful or helpful some of our food choices may be.

About the editor

Dr. Sérgio VencioEditor-in-Chief Dr. Sérgio Vencio is active in the field of Endocrinology. He is a professor in the Post Graduate Program at the Federal University of Goiás, a Principal Investigator at the Pharmaceutical Institute of Science and has participated as a PI in more than 70 clinical studies. Since 2008, he has been the Editor of the Brazilian Diabetes Society Guidelines. He is the Coordinator of Neuroendocrinology at the Hospital Araujo Jorge, the Medical Director at Diagnostics of America - Atalaia, and a member of the Diabetes Board for the Brazilian Society of Endocrinology.

Editor's quote

"Diabetology & Metabolic Syndrome was launched in 2009 as a fully open access journal. Supported by the Brazilian Diabetes Society since the very beginning, Diabetology & Metabolic Syndrome is now a truly international journal. Publishing human, animal and in vitro studies which are freely accessible to readers, we aim to accelerate research as well as help health care providers improve management of people afflicted by this pandemic condition."

Daniel Giannella-Neto, Former Editor-in-Chief

Advertisement


The official journal of the Brazilian Diabetes Society.

2017 Journal Metrics

Advertisement